Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 15, 2023 (Week 28)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 15,652 33,110 746,014 844,719
New England 586 1,468 22,839 26,754
Connecticut - 251 1,156 5,688
Maine 44 78 1,537 1,712
Massachusetts 426 709 15,451 14,519
New Hampshire 4 93 1,338 1,609
Rhode Island 91 694 2,628 2,579
Vermont 21 37 729 647
Middle Atlantic 2,771 4,218 103,549 102,527
New Jersey 465 788 18,560 17,656
New York (excluding New York City) 786 1,032 21,734 20,947
New York City 719 1,457 34,566 34,395
Pennsylvania 801 1,234 28,689 29,529
East North Central 1,987 4,840 100,964 122,050
Illinois 105 1,518 26,605 37,774
Indiana 383 858 15,364 17,739
Michigan 271 975 17,130 22,759
Ohio 809 1,223 28,537 29,757
Wisconsin 419 561 13,328 14,021
West North Central 906 2,120 45,658 54,092
Iowa 172 334 7,234 7,940
Kansas 118 300 2,288 7,502
Minnesota 171 496 11,464 11,866
Missouri 411 729 16,549 17,019
Nebraska - 223 3,869 5,206
North Dakota 31 92 1,758 1,928
South Dakota 3 125 2,496 2,631
South Atlantic 3,384 7,194 162,948 171,285
Delaware 92 420 3,090 5,406
District of Columbia 128 191 3,996 4,342
Florida 1,707 2,787 58,109 54,329
Georgia - 1,599 25,991 39,230
Maryland U NC U U
North Carolina 6 1,432 29,302 35,227
South Carolina 639 884 17,774 19,426
Virginia 796 976 22,447 11,059
West Virginia 16 107 2,239 2,266
East South Central 1,071 2,502 54,179 56,816
Alabama 692 972 18,265 16,446
Kentucky 239 425 8,398 9,682
Mississippi 140 526 9,309 10,053
Tennessee - 1,094 18,207 20,635
West South Central 806 4,934 79,232 126,029
Arkansas 207 392 8,395 9,654
Louisiana 411 801 18,366 19,613
Oklahoma 44 422 5,731 10,622
Texas 144 3,406 46,740 86,140
Mountain 1,469 2,495 55,016 54,872
Arizona 505 917 21,046 22,006
Colorado 472 791 13,999 5,828
Idaho 69 155 3,044 2,989
Montana - 112 1,474 2,219
Nevada 174 362 4,090 9,199
New Mexico 17 256 4,606 5,719
Utah 195 249 5,905 5,995
Wyoming 37 54 852 917
Pacific 2,672 5,045 121,629 130,294
Alaska 34 121 1,999 2,885
California 2,352 4,110 101,144 102,886
Hawaii - 2 - 68
Oregon 286 362 8,040 8,503
Washington - 635 10,446 15,952
U.S. Territories - 124 1,044 2,567
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 124 1,044 2,567
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 7 29 72
Total 15,652 33,210 747,087 847,358
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.